Purchase Order HHSN267200700595P

The U.S. National Institute of Allergy and Infectious Diseases (NIAID) awarded a Firm Fixed Price Purchase Order contract to Asischem Inc. to provide custom synthesis of a chemical compound. The contract, valued at $4,890.00, was awarded on August 3, 2015 with a completion date of December 1, 2015. This contract was not set aside for any specific business type or size. Based on the agency name, this contract is likely related to NIAID's research and development programs focused on infectious...

This is a $36,000.00 firm fixed-price contract awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), which is part of the National Institutes of Health (NIH), a civilian agency. The contract was awarded to Entrechem SL, a for-profit manufacturer located in Spain, to provide 100g each of two specialized chemical compounds, (1S,2S)-trans-N-Boc-Tetrahydro-3,4-furandiamine and (1R,2R)-trans-N-Boc-Tetrahydro-3,4-furandiamine. These compounds are needed as starting...

<p>The National Institute of Diabetes and Digestive and Kidney Diseases awarded a purchase order to Chem-Master International, Inc. for $13,900 on March 3, 2021, with ultimate completion by April 17, 2021. The order is firm fixed price with no set-aside. Work is performed in Smithtown, New York. The purchase covers chemical compound synthesis in support of NIDDK research activities.</p>

This federal contract award, valued at $50,000.00, was issued by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency within the Department of Health and Human Services, to the prime contractor Entrechem SL. The contract is for the purchase of 100 grams each of two specific enantiomers of trans-N-Boc-1,2-tetrahydro-3,4-furandiamine. These chemical compounds are needed as starting materials for the NIDDK's research into developing thyclotides, which...

<p>This is a $4,441.00 purchase order awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency, to Mimotopes PTY LTD for a set of 165 peptides, designated as PSACM0165-01 PEPSET OF 165 PEPTIDES. The contract has a performance period through October 30, 2007 and was awarded on September 12, 2007. The contract does not have a set-aside designation.</p>

<p>The National Institute of Diabetes and Digestive and Kidney Diseases awarded a purchase order to Creagen Inc. for $56,000 on August 10, 2026, with ultimate completion on August 9, 2027. Creagen is an SBA-certified 8(a) small disadvantaged business. No set-aside category was applied to this order. Work is performed in Bethesda, Maryland. The order is firm fixed price for chemistry-based drug discovery and scientific research services supporting the Institute's biomedical research mission.</p>

This is a $162,000 firm fixed-price purchase order awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to Frontage Laboratories, Inc., a full-service contract research organization (CRO), for the synthesis of thyclotides and cyclopentane-constrained peptide nucleic acids. The award was made on a sole-source basis under simplified acquisition procedures, as Frontage was determined to be the only source capable of scaling up the production of these...

This federal contract award, valued at $51,248.00, was issued by the National Institutes of Health's National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to Polyorg, Inc., a manufacturer of specialty chemicals. The award was a firm fixed-price purchase order for the delivery of 80 grams of A(Bhoc)-OH, 120 grams of C(Bhoc)-OH, and 160 grams of G(Bhoc)-OH, which are key building blocks for the development of thyclotides and cyclopentane peptide nucleic acids. These materials...

<p>This is a $12,000.00 firm fixed price purchase order awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency, to David A. Hall, a for-profit, veteran-owned business located in Rockville, Maryland. The contract is for a non-affiliated outside member as required by NIH policy and federal regulations. The contract has a period of performance through April 14, 2030. The contract has no set-aside designation.</p>

This firm fixed price purchase order contract was awarded to Cayman Chemical Co Inc., a leading supplier of biochemical products and research tools, by the National Institute of Allergy and Infectious Diseases (NIAID) under the National Institutes of Health (NIH). The contract has a ceiling value of $5,368.45 and was awarded on February 10, 2012, with a completion date of March 9, 2012. No set-aside designation was used for this award. Cayman Chemical Co Inc. specializes in the production of...